Synthetic plant virology for nanobiotechnology and nanomedicine

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 9, Issue 4, 2017, Pages

  Steele, John F C ^a   Peyret, Hadrien ^a   Saunders, Keith ^a   Castells Graells, Roger ^a   Marsian, Johanna ^a   Meshcheriakova, Yulia ^a   Lomonossoff, George P ^a  

^a JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL NANOTECHNOLOGY; NANOTECHNOLOGY;

ANTICANCER COMPOUNDS; FUNCTIONALIZATIONS; NANOSCALE STRUCTURE; NANOWIRE FORMATION; PHYSICAL AND CHEMICAL PROPERTIES; PLANT VIRUS; VACCINE PRODUCTION; VIRUS-LIKE PARTICLES;

VIRUSES;

NANOBIOTECHNOLOGY; NANOMEDICINE; PLANT; PRIORITY JOURNAL; REVIEW; VIROLOGY; NANOTECHNOLOGY; PLANT VIRUS; SYNTHETIC BIOLOGY;

NANOPARTICLE;

NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PLANT VIRUSES; SYNTHETIC BIOLOGY;

EID: 85020856623     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1447     Document Type: Review

References (162)

1. Stanley WM. Isolation of a crystalline protein possessing the properties of tobacco-mosaic virus. Science 1935, 81:644–645.
2. Bawden FC, Pirie NW, Bernal JD, Fankuchen I. Liquid crystalline substances from virus-infected plants. Nature 1936, 138:1051–1052.
3. Caspar DL, Klug A. Physical principles in the construction of regular viruses. Cold Spring Harb Symp Quant Biol 1962, 27:1–24.
4. Stubbs G, Warren S, Holmes K. Structure of RNA and RNA binding site in tobacco mosaic virus from 4-A map calculated from X-ray fibre diagrams. Nature 1977, 267:216–221.
5. Bloomer AC, Champness JN, Bricogne G, Staden R, Klug A. Protein disk of tobacco mosaic virus at 2.8 A resolution showing the interactions within and between subunits. Nature 1978, 276:362–368.
6. Harrison SC, Olson AJ, Schutt CE, Winkler FK, Bricogne G. Tomato bushy stunt virus at 2.9 A resolution. Nature 1978, 276:368–373.
7. Abad-Zapatero C, Abdel-Meguid SS, Johnson JE, Leslie AG, Rayment I, Rossmann MG, Suck D, Tsukihara T. Structure of southern bean mosaic virus at 2.8 A resolution. Nature 1980, 286:33–39.
8. Porta C, Lomonossoff GP. Use of viral replicons for the expression of genes in plants. Mol Biotechnol 1996, 5:209–221.
9. Varma A, Gibbs AJ, Woods RD, Finch JT. Some observations on structure of filamentous particles of several plant viruses. J Gen Virol 1968, 2:107–114.
10. Rossmann MG, Johnson JE. Icosahedral RNA virus structure. Annu Rev Biochem 1989, 58:533–573.
11. Lomonossoff GP, Johnson JE. The synthesis and structure of comovirus capsids. Prog Biophys Mol Biol 1991, 55:107–137.
12. Bancroft JB. The self-assembly of spherical plant viruses. Adv Virus Res 1970, 16:99–134.
13. Casjens S, King J. Virus assembly. Annu Rev Biochem 1975, 44:555–611.
14. Klug A. The tobacco mosaic virus particle: structure and assembly. Philos Trans R Soc Lond B Biol Sci 1999, 354:531–535.
15. Atabekov J, Dobrov E, Karpova O, Rodionova N. Potato virus X: structure, disassembly and reconstitution. Mol Plant Pathol 2007, 8:667–675.
16. Zhang W, Olson NH, Baker TS, Faulkner L, Agbandje-McKenna M, Boulton MI, Davies JW, McKenna R. Structure of the Maize streak virus geminate particle. Virology 2001, 279:471–477.
17. Brenner S, Horne RW. A negative staining method for high resolution electron microscopy of viruses. Biochim Biophys Acta 1959, 34:103–110.
18. Jeng TW, Crowther RA, Stubbs G, Chiu W. Visualization of alpha-helices in tobacco mosaic virus by cryo-electron microscopy. J Mol Biol 1989, 205:251–257.
19. Sachse C, Chen JZ, Coureux PD, Stroupe ME, Fandrich M, Grigorieff N. High-resolution electron microscopy of helical specimens: a fresh look at tobacco mosaic virus. J Mol Biol 2007, 371:812–835.
20. Fromm SA, Bharat TA, Jakobi AJ, Hagen WJ, Sachse C. Seeing tobacco mosaic virus through direct electron detectors. J Struct Biol 2015, 189:87–97.
21. Lomonossoff GP, Johnson JE. Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines. Curr Opin Struct Biol 1996, 6:176–182.
22. Lin T, Porta C, Lomonossoff G, Johnson JE. Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution. Fold Des 1996, 1:179–187.
23. Bragard C, Duncan GH, Wesley SV, Naidu RA, Mayo MA. Virus-like particles assemble in plants and bacteria expressing the coat protein gene of Indian peanut clump virus. J Gen Virol 2000, 81:267–272.
24. Zhao X, Fox JM, Olson NH, Baker TS, Young MJ. In vitro assembly of cowpea chlorotic mottle virus from coat protein expressed in Escherichia coli and in vitro-transcribed viral cDNA. Virology 1995, 207:486–494.
25. Brumfield S, Willits D, Tang L, Johnson JE, Douglas T, Young M. Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. J Gen Virol 2004, 85:1049–1053.
26. Kadri A, Wege C, Jeske H. In vivo self-assembly of TMV-like particles in yeast and bacteria for nanotechnological applications. J Virol Methods 2013, 189:328–340.
27. Mueller A, Kadri A, Jeske H, Wege C. In vitro assembly of tobacco mosaic virus coat protein variants derived from fission yeast expression clones or plants. J Virol Methods 2010, 166:77–85.
28. Young M, Willits D, Uchida M, Douglas T. Plant viruses as biotemplates for materials and their use in nanotechnology. Annu Rev Phytopathol 2008, 46:361–384.
29. Langeveld JP, Brennan FR, Martinez-Torrecuadrada JL, Jones TD, Boshuizen RS, Vela C, Casal JI, Kamstrup S, Dalsgaard K, Meloen RH, et al. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine 2001, 19:3661–3670.
30. Ochoa WF, Chatterji A, Lin T, Johnson JE. Generation and structural analysis of reactive empty particles derived from an icosahedral virus. Chem Biol 2006, 13:771–778.
31. Sainsbury F, Lomonossoff GP. Transient expressions of synthetic biology in plants. Curr Opin Plant Biol 2014, 19:1–7.
32. Peyret H, Lomonossoff GP. When plant virology met Agrobacterium: the rise of the deconstructed clones. Plant Biotechnol J 2015, 13:1121–1135.
33. Saunders K, Sainsbury F, Lomonossoff GP. Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants. Virology 2009, 393:329–337.
34. Hesketh EL, Meshcheriakova Y, Dent KC, Saxena P, Thompson RF, Cockburn JJ, Lomonossoff GP, Ranson NA. Mechanisms of assembly and genome packaging in an RNA virus revealed by high-resolution cryo-EM. Nat Commun 2015, 6:10113.
35. Huynh NT, Hesketh EL, Saxena P, Meshcheriakova Y, Ku YC, Hoang LT, Johnson JE, Ranson NA, Lomonossoff GP, Reddy VS. Crystal structure and proteomics analysis of empty virus-like particles of cowpea mosaic virus. Structure 2016, 24:567–575.
36. Sainsbury F, Saunders K, Aljabali AA, Evans DJ, Lomonossoff GP. Peptide-controlled access to the interior surface of empty virus nanoparticles. Chembiochem 2011, 12:2435–2440.
37. Wen AM, Shukla S, Saxena P, Aljabali AA, Yildiz I, Dey S, Mealy JE, Yang AC, Evans DJ, Lomonossoff GP, et al. Interior engineering of a viral nanoparticle and its tumor homing properties. Biomacromolecules 2012, 13:3990–4001.
38. Belval L, Hemmer C, Sauter C, Reinbold C, Fauny JD, Berthold F, Ackerer L, Schmitt-Keichinger C, Lemaire O, Demangeat G, et al. Display of whole proteins on inner and outer surfaces of grapevine fanleaf virus-like particles. Plant Biotechnol J 2016, 14:2288–2299.
39. Saunders K, Lomonossoff GP. The generation of turnip crinkle virus-like particles in plants by the transient expression of wild-type and modified forms of its coat protein. Front Plant Sci 2015, 6:1138.
40. Butler PJ. Self-assembly of tobacco mosaic virus: the role of an intermediate aggregate in generating both specificity and speed. Philos Trans R Soc Lond B Biol Sci 1999, 354:537–550.
41. Eiben S, Stitz N, Eber F, Wagner J, Atanasova P, Bill J, Wege C, Jeske H. Tailoring the surface properties of tobacco mosaic virions by the integration of bacterially expressed mutant coat protein. Virus Res 2014, 180:92–96.
42. Arkhipenko MV, Petrova EK, Nikitin NA, Protopopova AD, Dubrovin EV, Yaminskii IV, Rodionova NP, Karpova OV, Atabekov JG. Characteristics of artificial virus-like particles assembled in vitro from potato virus X coat protein and foreign viral RNAs. Acta Naturae 2011, 3:40–46.
43. Chen C, Daniel MC, Quinkert ZT, De M, Stein B, Bowman VD, Chipman PR, Rotello VM, Kao CC, Dragnea B. Nanoparticle-templated assembly of viral protein cages. Nano Lett 2006, 6:611–615.
44. Hu Y, Zandi R, Anavitarte A, Knobler CM, Gelbart WM. Packaging of a polymer by a viral capsid: the interplay between polymer length and capsid size. Biophys J 2008, 94:1428–1436.
45. Sun J, DuFort C, Daniel MC, Murali A, Chen C, Gopinath K, Stein B, De M, Rotello VM, Holzenburg A, et al. Core-controlled polymorphism in virus-like particles. Proc Natl Acad Sci U S A 2007, 104:1354–1359.
46. Hart RG. Morphological changes accompanying thermal denaturation of tobacco mosaic virus. Biochim Biophys Acta 1956, 20:388–389.
47. Atabekov J, Nikitin N, Arkhipenko M, Chirkov S, Karpova O. Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles. J Gen Virol 2011, 92:453–456.
48. Eber FJ, Eiben S, Jeske H, Wege C. RNA-controlled assembly of tobacco mosaic virus-derived complex structures: from nanoboomerangs to tetrapods. Nanoscale 2015, 7:344–355.
49. Cuenca S, Mansilla C, Aguado M, Yuste-Calvo C, Sanchez F, Sanchez-Montero JM, Ponz F. Nanonets derived from turnip mosaic virus as scaffolds for increased enzymatic activity of immobilized candida antarctica lipase B. Front Plant Sci 2016, 7:464.
50. Shukla S, Eber FJ, Nagarajan AS, DiFranco NA, Schmidt N, Wen AM, Eiben S, Twyman RM, Wege C, Steinmetz NF. The impact of aspect ratio on the biodistribution and tumor homing of rigid soft-matter nanorods. Adv Healthc Mater 2015, 4:874–882.
51. Shukla S, Ablack AL, Wen AM, Lee KL, Lewis JD, Steinmetz NF. Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X. Mol Pharm 2013, 10:33–42.
52. Porta C, Spall VE, Findlay KC, Gergerich RC, Farrance CE, Lomonossoff GP. Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology 2003, 310:50–63.
53. Lico C, Capuano F, Renzone G, Donini M, Marusic C, Scaloni A, Benvenuto E, Baschieri S. Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles. J Gen Virol 2006, 87:3103–3112.
54. Taylor KM, Lin T, Porta C, Mosser AG, Giesing HA, Lomonossoff GP, Johnson JE. Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus. J Mol Recognit 2000, 13:71–82.
55. Smolenska L, Roberts IM, Learmonth D, Porter AJ, Harris WJ, Wilson TM, Santa CS. Production of a functional single chain antibody attached to the surface of a plant virus. FEBS Lett 1998, 441:379–382.
56. Cruz SS, Chapman S, Roberts AG, Roberts IM, Prior DA, Oparka KJ. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci U S A 1996, 93:6286–6290.
57. Schlick TL, Ding Z, Kovacs EW, Francis MB. Dual-surface modification of the tobacco mosaic virus. J Am Chem Soc 2005, 127:3718–3723.
58. Demir MaS MH. A chemoselective biomolecular template for assembling diverse nanotubular materials. Nanotechnology 2002, 13:541.
59. Yi H, Nisar S, Lee SY, Powers MA, Bentley WE, Payne GF, Ghodssi R, Rubloff GW, Harris MT, Culver JN. Patterned assembly of genetically modified viral nanotemplates via nucleic acid hybridization. Nano Lett 2005, 5:1931–1936.
60. Koch C, Wabbel K, Eber FJ, Krolla-Sidenstein P, Azucena C, Gliemann H, Eiben S, Geiger F, Wege C. Modified TMV particles as beneficial scaffolds to present sensor enzymes. Front Plant Sci 2015, 6:1137.
61. Steinmetz NF, Lomonossoff GP, Evans DJ. Cowpea mosaic virus for material fabrication: addressable carboxylate groups on a programmable nanoscaffold. Langmuir 2006, 22:3488–3490.
62. Wang Q, Kaltgrad E, Lin T, Johnson JE, Finn MG. Natural supramolecular building blocks. Wild-type cowpea mosaic virus. Chem Biol 2002, 9:805–811.
63. Aljabali AA, Barclay JE, Steinmetz NF, Lomonossoff GP, Evans DJ. Controlled immobilisation of active enzymes on the cowpea mosaic virus capsid. Nanoscale 2012, 4:5640–5645.
64. Sen Gupta S, Kuzelka J, Singh P, Lewis WG, Manchester M, Finn MG. Accelerated bioorthogonal conjugation: A practical method for the Ligation of diverse functional molecules to a polyvalent virus scaffold. Bioconjug Chem 2005, 16:1572–1579.
65. Gonzalez MJ, Plummer EM, Rae CS, Manchester M. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS One 2009, 4:e7981.
66. Wang Q, Lin T, Johnson JE, Finn MG. Natural supramolecular building blocks. Cysteine-added mutants of cowpea mosaic virus. Chem Biol 2002, 9:813–819.
67. Meunier S, Strable E, Finn MG. Crosslinking of and coupling to viral capsid proteins by tyrosine oxidation. Chem Biol 2004, 11:319–326.
68. Gillitzer E, Willits D, Young M, Douglas T. Chemical modification of a viral cage for multivalent presentation. Chem Commun (Camb) 2002, 20:2390–2391.
69. Chatterji A, Ochoa WF, Paine M, Ratna BR, Johnson JE, Lin T. New addresses on an addressable virus nanoblock; uniquely reactive Lys residues on cowpea mosaic virus. Chem Biol 2004, 11:855–863.
70. Steinmetz NF, Lin T, Lomonossoff GP, Johnson JE. Structure-based engineering of an icosahedral virus for nanomedicine and nanotechnology. Curr Top Microbiol Immunol 2009, 327:23–58.
71. Lomonossoff GP, Evans DJ. Applications of plant viruses in bionanotechnology. Curr Top Microbiol Immunol 2014, 375:61–87.
72. Shah SN, Steinmetz NF, Aljabali AA, Lomonossoff GP, Evans DJ. Environmentally benign synthesis of virus-templated, monodisperse, iron-platinum nanoparticles. Dalton Trans 2009, 40:8479–8480.
73. Douglas TY. M Host–guest encapsulation of materials by assembled virus protein cages. Nature 1998, 393:152–155.
74. Douglas T, Strable E, Willits D, Aitouchen A, Libera M, Young M. Protein engineering of a viral cage for constrained nanomaterials synthesis. Advanced Materials 2002, 14:415–418.
75. Wen AM, Steinmetz NF. Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev 2016, 45:4074–4126.
76. van Kan-Davelaar HE, van Hest JC, Cornelissen JJ, Koay MS. Using viruses as nanomedicines. Br J Pharmacol 2014, 171:4001–4009.
77. Perez J, Defrenne S, Witz J, Vachette P. Detection and characterization of an intermediate conformation during the divalent ion-dependent swelling of tomato bushy stunt virus. Cell Mol Biol (Noisy-le-Grand) 2000, 46:937–948.
78. Grasso S, Lico C, Imperatori F, Santi L. A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus. Transgenic Res 2013, 22:519–535.
79. Loo L, Guenther RH, Lommel SA, Franzen S. Infusion of dye molecules into Red clover necrotic mosaic virus. Chem Commun (Camb) 2008, 88-90. DOI: 10.1039/B714748A.
80. Lockney DM, Guenther RN, Loo L, Overton W, Antonelli R, Clark J, Hu M, Luft C, Lommel SA, Franzen S. The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. Bioconjug Chem 2011, 22:67–73.
81. Zeng Q, Wen H, Wen Q, Chen X, Wang Y, Xuan W, Liang J, Wan S. Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Biomaterials 2013, 34:4632–4642.
82. Cao J, Guenther RH, Sit TL, Lommel SA, Opperman CH, Willoughby JA. Development of abamectin loaded plant virus nanoparticles for efficacious plant parasitic nematode control. ACS Appl Mater Interfaces 2015, 7:9546–9553.
83. Yildiz I, Lee KL, Chen K, Shukla S, Steinmetz NF. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. J Control Release 2013, 172:568–578.
84. Wen AM, Wang YM, Jiang K, Hsu GC, Gao HY, Lee KL, Yang AC, Yu X, Simon DI, Steinmetz NF. Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging. J Mater Chem B 2015, 3:6037–6045.
85. Czapar AE, Zheng YR, Riddell IA, Shukla S, Awuah SG, Lippard SJ, Steinmetz NF. Tobacco mosaic virus delivery of phenanthriplatin for cancer therapy. ACS Nano 2016, 10:4119–4126.
86. Adolph KW. The conformation of the RNA in cowpea chlorotic mottle virus: dye-binding studies. Eur J Biochem 1975, 53:449–455.
87. Tama F, Brooks CL 3rd. The mechanism and pathway of pH induced swelling in cowpea chlorotic mottle virus. J Mol Biol 2002, 318:733–747.
88. Azizgolshani O, Garmann RF, Cadena-Nava R, Knobler CM, Gelbart WM. Reconstituted plant viral capsids can release genes to mammalian cells. Virology 2013, 441:12–17.
89. Minten IJ, Ma Y, Hempenius MA, Vancso GJ, Nolte RJ, Cornelissen JJ. CCMV capsid formation induced by a functional negatively charged polymer. Org Biomol Chem 2009, 7:4685–4688.
90. Schoonen L, Pille J, Borrmann A, Nolte RJ, van Hest JC. Sortase A-mediated N-terminal modification of cowpea chlorotic mottle virus for highly efficient cargo loading. Bioconjug Chem 2015, 26:2429–2434.
91. Comellas-Aragones M, Engelkamp H, Claessen VI, Sommerdijk NA, Rowan AE, Christianen PC, Maan JC, Verduin BJ, Cornelissen JJ, Nolte RJ. A virus-based single-enzyme nanoreactor. Nat Nanotechnol 2007, 2:635–639.
92. Sanchez-Sanchez L, Cadena-Nava RD, Palomares LA, Ruiz-Garcia J, Koay MS, Cornelissen JJ, Vazquez-Duhalt R. Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450. Enzyme Microb Technol 2014, 60:24–31.
93. Lu X, Thompson JR, Perry KL. Encapsidation of DNA, a protein and a fluorophore into virus-like particles by the capsid protein of cucumber mosaic virus. J Gen Virol 2012, 93:1120–1126.
94. Koudelka KJ, Pitek AS, Manchester M, Steinmetz NF. Virus-Based Nanoparticles as versatile nanomachines. Annu Rev Virol 2015, 2:379–401.
95. Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 1993, 53:2379–2385.
96. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994, 73:2432–2443.
97. Rae CS, Khor IW, Wang Q, Destito G, Gonzalez MJ, Singh P, Thomas DM, Estrada MN, Powell E, Finn MG, et al. Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 2005, 343:224–235.
98. Singh P, Prasuhn D, Yeh RM, Destito G, Rae CS, Osborn K, Finn MG, Manchester M. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J Control Release 2007, 120:41–50.
99. Kaiser CR, Flenniken ML, Gillitzer E, Harmsen AL, Harmsen AG, Jutila MA, Douglas T, Young MJ. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int J Nanomedicine 2007, 2:715–733.
100. Bruckman MA, Randolph LN, VanMeter A, Hern S, Shoffstall AJ, Taurog RE, Steinmetz NF. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology 2014, 449:163–173.
101. Shukla S, Wen AM, Ayat NR, Commandeur U, Gopalkrishnan R, Broome AM, Lozada KW, Keri RA, Steinmetz NF. Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice. Nanomedicine (Lond) 2014, 9:221–235.
102. Lee KL, Shukla S, Wu M, Ayat NR, El Sanadi CE, Wen AM, Edelbrock JF, Pokorski JK, Commandeur U, Dubyak GR, et al. Stealth filaments: polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X. Acta Biomater 2015, 19:166–179.
103. Steinmetz NF, Manchester M. PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo. Biomacromolecules 2009, 10:784–792.
104. Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog 2009, 5:e1000417.
105. Lee KL, Carpenter BL, Wen AM, Ghiladi RA, Steinmetz NF. High aspect ratio nanotubes formed by tobacco mosaic virus for delivery of photodynamic agents targeting melanoma. ACS Biomat Sci Eng 2016, 2:838–844.
106. Koistinen P, Heino J. Integrins in Cancer Cell Invasion. Madam Curie Bioscience. Austin, TX: Landes Bioscience; 2000-2013.
107. Hovlid ML, Steinmetz NF, Laufer B, Lau JL, Kuzelka J, Wang Q, Hyypia T, Nemerow GR, Kessler H, Manchester M, et al. Guiding plant virus particles to integrin-displaying cells. Nanoscale 2012, 4:3698–3705.
108. Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007, 59:748–758.
109. Ren Y, Wong SM, Lim LY. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem 2007, 18:836–843.
110. Steinmetz NF, Mertens ME, Taurog RE, Johnson JE, Commandeur U, Fischer R, Manchester M. Potato virus X as a novel platform for potential biomedical applications. Nano Lett 2010, 10:305–312.
111. Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nat Med 2006, 12:354–360.
112. Cho CF, Ablack A, Leong HS, Zijlstra A, Lewis J. Evaluation of nanoparticle uptake in tumors in real time using intravital imaging. J Vis Exp 2011, 21:2808.
113. Leong HS, Steinmetz NF, Ablack A, Destito G, Zijlstra A, Stuhlmann H, Manchester M, Lewis JD. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat Protoc 2010, 5:1406–1417.
114. Chariou PL, Lee KL, Wen AM, Gulati NM, Stewart PL, Steinmetz NF. Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle. Bioconjug Chem 2015, 26:262–269.
115. Kim D, Moon H, Baik SH, Singha S, Jun YW, Wang T, Kim KH, Park BS, Jung J, Mook-Jung I, et al. Two-photon absorbing dyes with minimal autofluorescence in tissue imaging: application to in vivo imaging of amyloid-beta plaques with a negligible background signal. J Am Chem Soc 2015, 137:6781–6789.
116. Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence microscopy. Science 1990, 248:73–76.
117. Squirrell JM, Wokosin DL, White JG, Bavister BD. Long-term two-photon fluorescence imaging of mammalian embryos without compromising viability. Nat Biotechnol 1999, 17:763–767.
118. Niehl A, Appaix F, Bosca S, van der Sanden B, Nicoud JF, Bolze F, Heinlein M. Fluorescent tobacco mosaic virus-derived bio-nanoparticles for intravital two-photon imaging. Front Plant Sci 2015, 6:1244.
119. Shriver LP, Plummer EM, Thomas DM, Ho S, Manchester M. Localization of gadolinium-loaded CPMV to sites of inflammation during central nervous system autoimmunity. J Mater Chem B 2013, 1:5256–5263.
120. Bruckman MA, Yu X, Steinmetz NF. Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening. Nanotechnology 2013, 24:462001.
121. Rezapkin GV, Chumakov KM, Lu Z, Ran Y, Dragunsky EM, Levenbook IS. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Virology 1994, 202:370–378.
122. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 1987, 330:381–384.
123. Francis MJ, Hastings GZ, Brown AL, Grace KG, Rowlands DJ, Brown F, Clarke BE. Immunological properties of hepatitis B core antigen fusion proteins. Proc Natl Acad Sci U S A 1990, 87:2545–2549.
124. Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. WIREs Nanomed Nanobiotechnol 2011, 3:174–196.
125. Usha R, Rohll JB, Spall VE, Shanks M, Maule AJ, Johnson JE, Lomonossoff GP. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology 1993, 197:366–374.
126. Porta C, Spall VE, Loveland J, Johnson JE, Barker PJ, Lomonossoff GP. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology 1994, 202:949–955.
127. McLain L, Porta C, Lomonossoff GP, Durrani Z, Dimmock NJ. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retroviruses 1995, 11:327–334.
128. Dalsgaard K, Uttenthal A, Jones TD, Xu F, Merryweather A, Hamilton WD, Langeveld JP, Boshuizen RS, Kamstrup S, Lomonossoff GP, et al. Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 1997, 15:248–252.
129. Turpen TH, Reinl SJ, Charoenvit Y, Hoffman SL, Fallarme V, Grill LK. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Biotechnology (N Y) 1995, 13:53–57.
130. Sugiyama Y, Hamamoto H, Takemoto S, Watanabe Y, Okada Y. Systemic production of foreign peptides on the particle surface of tobacco mosaic virus. FEBS Lett 1995, 359:247–250.
131. Koo M, Bendahmane M, Lettieri GA, Paoletti AD, Lane TE, Fitchen JH, Buchmeier MJ, Beachy RN. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci U S A 1999, 96:7774–7779.
132. Zhao X, Chen L, Luckanagul JA, Zhang X, Lin Y, Wang Q. Enhancing antibody response against small molecular hapten with tobacco mosaic virus as a polyvalent carrier. Chembiochem 2015, 16:1279–1283.
133. Arora U, Tyagi P, Swaminathan S, Khanna N. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice. Vaccine 2013, 31:873–878.
134. Middelberg AP, Rivera-Hernandez T, Wibowo N, Lua LH, Fan Y, Magor G, Chang C, Chuan YP, Good MF, Batzloff MR. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 2011, 29:7154–7162.
135. Mazeike E, Gedvilaite A, Blohm U. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope. Virus Res 2012, 163:2–10.
136. Pniewski T, Kapusta J, Bociag P, Wojciechowicz J, Kostrzak A, Gdula M, Fedorowicz-Stronska O, Wojcik P, Otta H, Samardakiewicz S, et al. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J Appl Genet 2011, 52:125–136.
137. Nuzzaci M, Vitti A, Condelli V, Lanorte MT, Tortorella C, Boscia D, Piazzolla P, Piazzolla G. In vitro stability of Cucumber mosaic virus nanoparticles carrying a Hepatitis C virus-derived epitope under simulated gastrointestinal conditions and in vivo efficacy of an edible vaccine. J Virol Methods 2010, 165:211–215.
138. Denis J, Majeau N, Acosta-Ramirez E, Savard C, Bedard MC, Simard S, Lecours K, Bolduc M, Pare C, Willems B, et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology 2007, 363:59–68.
139. D'Aoust MA, Lavoie PO, Couture MM, Trepanier S, Guay JM, Dargis M, Mongrand S, Landry N, Ward BJ, Vezina LP. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J 2008, 6:930–940.
140. Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson AL, Rybicki EP. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol 2007, 88:1460–1469.
141. Millan AFS, Ortigosa SM, Hervas-Stubbs S, Corral-Martinez P, Segui-Simarro JM, Gaetan J, Coursaget P, Veramendi J. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J 2008, 6:427–441.
142. Matic S, Masenga V, Poli A, Rinaldi R, Milne RG, Vecchiati M, Noris E. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J 2012, 10:410–421.
143. Pineo CB, Hitzeroth II, Rybicki EP. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. Plant Biotechnol J 2013, 11:964–975.
144. Love AJ, Chapman SN, Matic S, Noris E, Lomonossoff GP, Taliansky M. In planta production of a candidate vaccine against bovine papillomavirus type 1. Planta 2012, 236:1305–1313.
145. Scotti N, Alagna F, Ferraiolo E, Formisano G, Sannino L, Buonaguro L, De Stradis A, Vitale A, Monti L, Grillo S, et al. High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. Planta 2009, 229:1109–1122.
146. Mathew LG, Herbst-Kralovetz MM, Mason HS. Norovirus Narita 104 virus-like particles expressed in Nicotiana benthamiana induce serum and mucosal immune responses. Biomed Res Int 2014, 2014:807539.
147. Yang Y, Li X, Yang H, Qian Y, Zhang Y, Fang R, Chen X. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Sci China Life Sci 2011, 54:82–89.
148. Thuenemann EC, Meyers AE, Verwey J, Rybicki EP, Lomonossoff GP. A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 2013, 11:839–846.
149. Mechtcheriakova IA, Eldarov MA, Nicholson L, Shanks M, Skryabin KG, Lomonossoff GP. The use of viral vectors to produce hepatitis B virus core particles in plants. J Virol Methods 2006, 131:10–15.
150. Marsian J, Lomonossoff GP. Molecular pharming – VLPs made in plants. Curr Opin Biotechnol 2016, 37:201–206.
151. Shenton W, Douglas T, Young M, Stubbs G, Mann S. Inorganic-organic nanotube composites from template mineralization of tobacco mosaic virus. Adv Mater 1999, 11:253–256.
152. Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol Pharm 2011, 8:29–43.
153. Douglas T, Young M. Virus particles as templates for materials synthesis. Adv Mater 1999, 11:679–681.
154. Aljabali AA, Sainsbury F, Lomonossoff GP, Evans DJ. Cowpea mosaic virus unmodified empty viruslike particles loaded with metal and metal oxide. Small 2010, 6:818–821.
155. Heddle JG. Protein cages, rings and tubes: useful components of future nanodevices? Nanotechnol Sci Appl 2008, 1:67–78.
156. Aljabali AA, Lomonossoff GP, Evans DJ. CPMV-polyelectrolyte-templated gold nanoparticles. Biomacromolecules 2011, 12:2723–2728.
157. Tseng RJ, Tsai CL, Ma LP, Ouyang JY. Digital memory device based on tobacco mosaic virus conjugated with nanoparticles. Nat Nanotechnol 2006, 1:72–77.
158. Gorzny ML, Walton AS, Wnek M, Stockley PG, Evans SD. Four-probe electrical characterization of Pt-coated TMV-based nanostructures. Nanotechnology 2008, 19:165704.
159. Knez M, Bittner AM, Boes F, Wege C, Jeske H, Maiss E, Kern K. Biotemplate synthesis of 3-nm nickel and cobalt nanowires. Nano Lett 2003, 3:1079–1082.
160. Tsukamoto R, Muraoka M, Seki M, Tabata H, Yamashita I. Synthesis of CoPt and FePt3 nanowires using the central channel of tobacco mosaic virus as a biotemplate. Chem Mater 2007, 19:2389–2391.
161. Kapoor P, Singh H, Gautam A, Chaudhary K, Kumar R, Raghava GP. TumorHoPe: a database of tumor homing peptides. PLoS One 2012, 7:e35187.
162. Rademacher T. Method for the generation and cultivation of a plant cell pack. EP 2012-2623603 A1: 20130807, Fraunhofer Institute, 2013.